Get Started

EPRX

NASD Eupraxia Pharmaceuticals, Inc.
Nov 10, 2026 · 1:47 PM ET DELAYED Market Open

$7.47 ↑ +0.05 (+0.67%) Trading Up from the previous close of $7.42, $0.08 below the day’s high of $7.55

YTD change
-1.06%
vs 20-day SMA
+6.65%
vs 200-day SMA
+3.08%

Price ranges

Previous day
$6.94 $7.65
open $7.23 close $7.42
+$0.19 (+2.63%)
Today
$7.20 $7.55
open $7.33 now $7.47
+$0.14 (+1.91%)
Past week
$6.30 $7.65
from $6.76 now $7.47
+$0.71 (+10.50%)
Past month
$6.30 $7.94
from $7.32 now $7.47
+$0.15 (+2.05%)
This year
$5.63 $9.32
from $7.55 now $7.47
-$0.08 (-1.06%)

Price & Performance

+0.00 (+0.00%) / 6M

$5.55$6.82$8.09$9.36May 11Aug 11Nov 9

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 19.8% away from all-time highs of $9.32
  • EPRX is down 1% since the beginning of the year
  • EPRX is up 20% over the past 12 months
  • EPRX is up 2% over the past 1 month
  • 10% of all EPRX investors are betting against EPRX

EPRX reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +19.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.221461
Earnings momentum +15.5% Quarterly EPS growth
Quarterly change +15.5%

Valuation

P/E ratio N/A
Enterprise value $386.3M
Beta 1.32

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$133.7M
Debt$1.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $489.1M

Eupraxia Pharmaceuticals, Inc. operates as a drug delivery technology company in Canada. It delivers drugs into body compartments, such as the joint without any of the common issues with body compartment injections, such as systemic exposure. The firm focuses on arthritis, diabetic macular edema, and chronic pain programs. The company was founded by James A. Helliwell, John Salvatore Montalbano and Amanda Malone on May 12, 2011 and is headquartered in Victoria, Canada.

Competitor comparison

TickerCompany PriceChange
ARGNF argenx SE $900.30 N/A
GNNSF Genscript Biotech Corporation $3.95 -12.22%
GLXY Galaxy Digital Inc. Class A $14.51 +6.22%
PVLA Palvella Therapeutics, Inc. $174.08 -1.05%
CLRPF Clarity Pharmaceuticals Ltd. $1.11 +4.25%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.